# Comparative Pharmacokinetic, Pharmacodynamic, and Safety Study of 1 Dose Level of Aspirin for Injection and Oral Aspirin Tablets in Healthy Adult Human Subjects

> **NCT05166096** · PHASE1 · COMPLETED · sponsor: **Rhoshan Pharmaceuticals Inc** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Rho-11
- **DRUG:** aspirin 325mg

## Key facts

- **NCT ID:** NCT05166096
- **Lead sponsor:** Rhoshan Pharmaceuticals Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-03
- **Primary completion:** 2022-05-11
- **Final completion:** 2022-05-11
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2022-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05166096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05166096, "Comparative Pharmacokinetic, Pharmacodynamic, and Safety Study of 1 Dose Level of Aspirin for Injection and Oral Aspirin Tablets in Healthy Adult Human Subjects". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05166096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*